O2 if hypoxic, keep pt calm.
Iv access.
ENT or pulmonary consult immediately if in trachea, mainstem bronchus or beyond (Endoscopy 1977;9:216).
by acetyl groups, may be genetic as well. Food sulfites may precipitate an exacerbation, as may exposure to cigarette smoke.
X-ray: Chest film if severe, febrile, or not following classic asthma pathway.
O2, if hypoxic.
Control airway, rapid sequence intubation if pt losing consciousness or in 1 word or less dyspnea and not responding— safer to do earlier rather than later, ie, do not wait for pt to have cardiopulmonary arrest (Crit Care Med 1993;21:1727).
When intubated, permissive hypercapnia (underventilating) is safe and appropriate (Chest 1994;105:891).
β-agonists—nebulized albuterol at 0.1-0.15 mg/kg up to 5 mg/dose if > 40 lbs, may select as continuous at 10 mg/hr, all suspended in NS; terbutaline (Brethine) 1 cc in 2 cc of NS; or bitolterol (Tornalate)—all probably equally effective. Inhaler with spacer as effective as nebulizers, if able to use effectively (J Peds 2000;136:497) and 5 puffs every 20 min in adult (Chest 2002;121:1036)—10 puffs equivalent to unit dose of albuterol nebulizer.
Ipratropium (Atrovent) is not approved for long-term maintenance (Nejm 1992;327:1413) but the literature supports acute use to decrease hospitalization in children with asthma (Nejm 1998;339:1030); consider dosing with albuterol at 0.5 cc in nebulized solution (Duoneb) for those with severe exacerbations or not responding to β-agonists, definitely not a chronic rx choice (Plotnick, L. H. and F. M. Ducharme (2000). “Combined inhaled anticholinergic agents and beta-2-agonists for initial treatment of acute asthma in children.” Cochrane Database Syst Rev 2).
Steroids—Hydrocortisone (100-300 mg every 6 hr), dexamethasone (4-8 mg every 8 hr), methylprednisolone (1-1.5 mg/kg iv every 12 hr) and prednisone (1-2 mg/kg qd) all equal at appropriate doses and give in ER; route of administration does not matter as far as onset of action or efficacy (6-8 hr or longer for onset of action). Outpatient rx should include a short course of steroids which may be extended depending on patient history (Rowe, B. H., C. H. Spooner, et al. (2000). “Corticosteroids for preventing relapse following acute exacerbations of asthma.” Cochrane Database Syst Rev 2). Consider inhaled steroids such as triamcinolone or budesonide, and perhaps some benefit in combining oral and inhaled steroids (Jama 1999;281:2119).
MgSO4 2 gm iv or nebulized (2.5-3 cc isotonic) (Am J Med 2000;108:193) may help in severe cases (Rowe, B. H., J. A. Bretzlaff, et al. (2000). “Magnesium sulfate for treating exacerbations of acute asthma in the emergency department.” Cochrane Database Syst Rev 2), but not suggested for routine use in any pts, especially peds (Ann EM 2000;36:572).
Aminophylline may be considered in severe cases, load at 5.6 mg/kg over 20-30 min, then 0.5 mg/kg/hr; decrease dose in those with CHF, liver disease, pneumonia, or h/o cardiac dysrhythmia.
Consider Heliox (60-80% helium), probably better in sick pts (Chest 1999;116:296) vs (Am J Emerg Med 2000;18:495). Albuterol nebulized with Heliox 80:20 had better spirometry after 3 treatments when compared with albuterol nebulized with air (Am J Respir Crit Care Med 2002;165:1317).
IVF important in severe cases, will need NaCl and KCl to reverse chloride depletion, be wary of pulmonary edema—ie, avoid fluid overload!
Antibiotics if bacterial focus or severe: Consider TMP/SMX DS 1 pill bid or see options under CAP (p425)—caution with those on theophylline.
May consider NaHCO3 for severe acidosis if intubated, but do not overcorrect.
Internal medicine/primary care ER consult for those needing admission, outpatient follow-up with steroid taper for those with good response to rx—peak flows ideally > 80% predicted. As well, intervention in pediatric pts with home intervention on allergens and tobacco smoke will decrease morbidity (Nejm 2004;351:1068).
Salmeterol (Serevent), montelukast (Singulair), zafirlukast (Accolate), zileuton (Zyflo), cromolyn (Intal), nedocromil (Tilade) and the decision for outpatient theophylline (Slo-bid, Theodur)
should be part of the outpatient physician’s realm or perhaps to help get pt off of ventilator.
Heparin is anti-inflammatory, its exact role in asthma has not been elucidated (Ann Pharmacother 2001;35:1161).
The role of 40 mg of nebulized furosemide to be determined, and one study claims a modest success (J Asthma 1998;35:89).
and this is a dose-dependent phenomenon for those on PPI’s (but not H2-blockers) (Jama 2004;292:1955).
Table 22.1 Patient Outcomes Research Team Score | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|